StockNews.com Begins Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)
StockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research note published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Stock Down 6.5 % Shares of CYCC stock opened at $0.29 on Friday. The stock has a 50-day moving average price of […]
More Stories
CCM Investment Advisers LLC Trims Stock Position in Walmart Inc. (NYSE:WMT)
CCM Investment Advisers LLC trimmed its holdings in Walmart Inc. (NYSE:WMT – Free Report) by 1.4% in the 4th quarter,...
The Lawsuits Targeting President-elect Trump
By Sam Dorman the_lawsuits_targeting_presidentelect_trumpDownload… Source
Atlas Brown Inc. Buys 170 Shares of Fidelity MSCI Information Technology Index ETF (NYSEARCA:FTEC)
Atlas Brown Inc. increased its stake in shares of Fidelity MSCI Information Technology Index ETF (NYSEARCA:FTEC – Free Report) by...
Atlas Brown Inc. Has $387,000 Stock Position in iShares MSCI USA Min Vol Factor ETF (BATS:USMV)
Atlas Brown Inc. lessened its stake in shares of iShares MSCI USA Min Vol Factor ETF (BATS:USMV – Free Report)...
Bruce G. Allen Investments LLC Purchases 869 Shares of Capital Group Dividend Value ETF (NYSEARCA:CGDV)
Bruce G. Allen Investments LLC grew its position in Capital Group Dividend Value ETF (NYSEARCA:CGDV – Free Report) by 12.3%...
abrdn Bloomberg All Commodity Strategy K-1 Free ETF (NYSEARCA:BCI) Shares Bought by Bruce G. Allen Investments LLC
Bruce G. Allen Investments LLC increased its position in abrdn Bloomberg All Commodity Strategy K-1 Free ETF (NYSEARCA:BCI – Free...